CALGB 70604 (Alliance): A randomized phase III study of standard dosing vs. longer interval dosing of zoledronic acid in metastatic cancer
- Citation:
- J Clin Oncol vol 33 (suppl) abstr 9501
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2452
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA037447, U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Andrew L. Himelstein Rui Qin Paul J. Novotny Drew K. Seisler James L. Khatcheressian John D. Roberts Stephen S. Grubbs Tracey O'Connor Douglas Weckstein Charles L. Loprinzi Charles L. Shapiro
- Networks:
- CHRISTIANA, LAPS-MN026, LAPS-NY158, NH038, NY021, VCU
- Study
- CALGB-70604
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: